The effect of the implantable two-channel peroneal nerve stimulator as a treatment in stroke patients with a drop foot in comparison with the conventional treatment

Not Applicable

Completed

• Conditions: Dropfoot, stroke; Circulatory System; Stroke, not specified as haemorrhage or infarction

• Registration Number: ISRCTN75455247
• Lead Sponsor: Roessingh Research and Development B.V. (The Netherlands)

Brief Summary

2007 results in: https://www.ncbi.nlm.nih.gov/pubmed/17678657 (added 04/07/2019)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2005-12-31
• Study Start: 2006-01-27
• Last Update Posted: 29 July 2019

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 29

Inclusion Criteria

1. Dropped foot identified by an inability to achieve a normal heel strike during walking
2. First hemiplegia of at least 6 months as a result of a cerebrovascular accident (CVA) with a stable neurology
3. Successful functional recovery after surface stimulation of the common peroneal nerve
4. Subject is an outdoor walker
5. Able to give informed consent

Exclusion Criteria

1. Aged less than 18 years
2. Passive dorsiflexion of the ankle less than 5º with knee in extension
3. Medical conditions limiting the function of walking other than CVA, i.e. neurological, rheumatic, cardio-vascular or systemic disorders (including Diabetes Mellitus)
4. Injury of N. peroneus or N. ischiadicus
5. Not be able to don and doff the equipment
6. Pregnancy

Study & Design

• Study Type: Interventional
• Study Design: Not specified